FDA inspection
Fresenius Kabi USA, LLC: FDA inspection ending Jun 29, 2018
FDA inspection 1059868 · Voluntary Action Indicated (VAI) · Grand Island, NY
Key facts
| Inspection ID | 1059868 |
|---|---|
| Firm | Fresenius Kabi USA, LLC |
| FEI number | 3001833549 |
| Address | 3159 Staley Rd |
| City | Grand Island |
| State | NY |
| ZIP | 14072-2028 |
| Fiscal year | 2018 |
| Inspection end date | Jun 29, 2018 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Generic Drug Evaluation |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data